The renewed effort to decide scientific ethics described in the article is unique
because it places patients and affected citizens of the decision-making process,
rather than leaving such decisions only to scientists. Policymakers, or
government officials. For the first time, a citizens’ jury made up of people
whose lives have been directly affected by hereditary diseases was asked to
evaluate whether genome editing of human embryos should be allowed. This
approach emphasizes transparency, inclusivity, and lived experience, making
ethical decision-making more democratic and socially grounded.
The issue is contentious because there are two main perspectives. One
perspective Supporters argue that this Technology could prevent severe
suffering, reduce inherited diseases, and improve quality of life for future
generations. They believe that, if carefully regulated, genome editing can be an
ethical and compassionate medical solution. The opposing perspective raises
concerns about the morals, social, and safety risks of editing human embryos.
Critics worry about unintended genetic consequences, unequal access to
treatment, and the possibility of misuse, such as “designer babies.” They argue
that changing human genetics raises profound ethical questions that society
may not yet be fully prepared to handle.
In my personal opinion, I align more closely with the perspective that supports
genome editing under strict ethical regulation. When people who directly
affected by genetic diseases support this option, their voices deserve serious
consideration. However, strong safeguards are essential to ensure
transparency, fairness, and equal access, as highlighted in the jury’s
recommendations.
My opinion has been influenced by my experience as a student learning about
genetic disorders and their lifelong impact on individuals and families.
Understanding how inherited conditions can limit daily life has helped me see
why affected individuals may support genome editing as a form of treatment,
not enhancement. This reinforces my belief that ethical science prioritize
reducing human suffering while remaining carefully regulated.
because it places patients and affected citizens of the decision-making process,
rather than leaving such decisions only to scientists. Policymakers, or
government officials. For the first time, a citizens’ jury made up of people
whose lives have been directly affected by hereditary diseases was asked to
evaluate whether genome editing of human embryos should be allowed. This
approach emphasizes transparency, inclusivity, and lived experience, making
ethical decision-making more democratic and socially grounded.
The issue is contentious because there are two main perspectives. One
perspective Supporters argue that this Technology could prevent severe
suffering, reduce inherited diseases, and improve quality of life for future
generations. They believe that, if carefully regulated, genome editing can be an
ethical and compassionate medical solution. The opposing perspective raises
concerns about the morals, social, and safety risks of editing human embryos.
Critics worry about unintended genetic consequences, unequal access to
treatment, and the possibility of misuse, such as “designer babies.” They argue
that changing human genetics raises profound ethical questions that society
may not yet be fully prepared to handle.
In my personal opinion, I align more closely with the perspective that supports
genome editing under strict ethical regulation. When people who directly
affected by genetic diseases support this option, their voices deserve serious
consideration. However, strong safeguards are essential to ensure
transparency, fairness, and equal access, as highlighted in the jury’s
recommendations.
My opinion has been influenced by my experience as a student learning about
genetic disorders and their lifelong impact on individuals and families.
Understanding how inherited conditions can limit daily life has helped me see
why affected individuals may support genome editing as a form of treatment,
not enhancement. This reinforces my belief that ethical science prioritize
reducing human suffering while remaining carefully regulated.
